Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: A pilot study

This publication has 21 references indexed in Scilit:

• A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD
  Pulmonary Pharmacology & Therapeutics, 2007
• The Effect of Tiotropium on Hyperinflation and Exercise Capacity in Chronic Obstructive Pulmonary Disease
  Respiration, 2006
• The effect of tiotropium on exacerbations and airflow in patients with COPD
  European Respiratory Journal, 2006
• Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD
  Pulmonary Pharmacology & Therapeutics, 2005
• Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
  European Respiratory Journal, 2004
• Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease
  European Respiratory Journal, 2003
• Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD
  Thorax, 2003
• Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
  The Lancet, 2003
• A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
  European Respiratory Journal, 2002
• Tiotropium (SPIRIVA™): Mechanistical considerations and clinical profile in obstructive lung disease
  Life Sciences, 1999